Alexander Y. Tokman
CEO & ChairmanMr. Alexander Y. Tokman, also known as Alex, served as an Acting CEO and Director at ENDRA Life Sciences Inc. from August 13, 2024 to 2025 and also serves as its Chief Executive Officer since 2025 and also serves as its Chairman since August 13, 2024. He serves as Independent Director at Izotropic Corporation since November 11, 2022. He serves on the Board of the American Academy of Thermography. He serves as President and Director of iUNU, Inc. Mr. Tokman was an Independent Director at ENDRA Life Sciences Inc. since 2008. Mr. Tokman served as the President of Microvision, Inc. since July 2005 until November 13, 2017 and served as its Chief Executive Officer from January 2006 to November 13, 2017. Mr. Tokman served as the Chief Operating Officer of Microvision Inc., from July 18, 2005 to January 2006. Previously, Mr. Tokman completed a 10+ year tenure as an executive with GE Healthcare, where he led several global businesses. He joined Microvision from GE Healthcare, a subsidiary of General Electric, where he served as a General Manager of its Global Molecular Imaging & Radiopharmacy unit from 2003 to 2005. He was the CEO-in-Residence at the Allen Institute for Artificial Intelligence (AI2), from 2019 to 2020. Between 1995 and 2003, Mr. Tokman served in various leadership roles at GE Healthcare. He has led cross-functional business and operations teams that developed and executed operating plans that produced double-digit growth in revenue and profitability. While improving the operational effectiveness of newly acquired businesses, Mr. Tokman implemented several key GE best practices, including multi-generational business and technology roadmaps, product development discipline, go-to-market strategies and 6 Sigma Quality initiatives. His achievements also include leading the strategic definition, development and commercialization of a new GE business segment that introduced several breakthrough imaging products based on a new hybrid Positron and Computed Tomography PET/CT technology that has transformed the way oncology is practiced today in hospitals and that added over 500 million in incremental organic revenue in the first few years of its commercial introduction. He serves as Member of Advisory Board at Izotropic Corporation since September 15, 2020. He served as a Director of Microvision Inc. from January 2006 to November 13, 2017. He has industry expertise and significant executive leadership and Director experience. As one of GE's Six Sigma and Design for Six Sigma (DFSS) pioneers, Mr. Tokman drove the quality culture change across GE Healthcare as a certified Black Belt and Master Black Belt in the late 1990s. Mr. Tokman is a growth-driven executive with cross-functional leadership and P&L management experience, focusing on the development and commercialization of new technology products and services across various markets including Medical Device, Biotech, Consumer Electronics, AI and AgTech. He has a proven track record in driving revenue growth and valuations for start-ups, micro-caps. His past roles include President of a privately held AI/Computer Vision SaaS company, CEO-in-Residence at the Allen Institute for Artificial Intelligence (AI2) and leadership roles at GE Healthcare. Mr. Tokman is a certified Six Sigma Black Belt. From 1989 to 1995, Mr. Tokman served as Development Programs Lead and a Head of Industry and Regional Development at Tracor Applied Sciences (BAE Systems). Mr. Tokman has both an M. S. and BS in Electrical Engineering from the University of Massachusetts, Dartmouth.
Positions
- Company NameENDRA Life Sciences Inc.Stock CodeNDRAPositionCEO & ChairmanColleagues
